Not only the EGFR mutations are seldom observed in NPC, but also tyrosine kinase inhibitors don’t seem beneficial [9], it raises questions about the carcinogenicity of EGFR might be independent of its tyrosine kinase activity in NPC [46]. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.